Al Gore-led fund leads $95-million investment in Toronto’s BenchSci, which uses AI to hasten drug discovery
Toronto-based BenchSci, which helps pharmaceutical firms accelerate research and development (R&D) using artificial intelligence (AI), has ... Read More